Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-13-030665)

Filing Details

Accession Number:: 0001209191-13-030665
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-06-04 20:28:52
Reporting Period:: 2013-06-04

Filing Date:: 2013-06-04
Accepted Time:: 2013-06-04 20:28:52
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1516479	Insys Therapeutics Inc.	INSY	Pharmaceutical Preparations (2834)	510327886

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1368078	L Michael Babich	444 South Ellis Street Chandler AZ 85224	President And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2013-06-04	1,250	$10.93	77,557	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

The weighted average sales price for the transaction reported was $10.92872, and the range of prices were between $10.924 and $10.9299. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.